1-Benzyloxymethyl-2-(hydroxyimino-methyl)-3-methyl-3H-imidazol-1-ium chloride

ID: ALA284692

Chembl Id: CHEMBL284692

Max Phase: Preclinical

Molecular Formula: C13H16ClN3O2

Molecular Weight: 246.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1cc[n+](COCc2ccccc2)c1/C=N/O.[Cl-]

Standard InChI:  InChI=1S/C13H15N3O2.ClH/c1-15-7-8-16(13(15)9-14-17)11-18-10-12-5-3-2-4-6-12;/h2-9H,10-11H2,1H3;1H

Standard InChI Key:  PRSGGQYVNLJACX-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 246.29

Molecular Weight (Monoisotopic): 246.1237

AlogP: 1.29

#Rotatable Bonds: 5

Polar Surface Area: 50.63

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.02

CX Basic pKa: ┄

CX LogP: -1.78

CX LogD: -2.25

Aromatic Rings: 2

Heavy Atoms: 18

QED Weighted: 0.37

Np Likeness Score: -0.32

References

1. Bedford CD, Harris RN, Howd RA, Miller A, Nolen HW, Kenley RA..  (1984)  Structure-activity relationships for reactivators of organophosphorus-inhibited acetylcholinesterase: quaternary salts of 2-[(hydroxyimino)methyl]imidazole.,  27  (11): [PMID:6492073] [10.1021/jm00377a010]

2. Bedford CD, Harris RN, Howd RA, Goff DA, Koolpe GA, Petesch M, Miller A, Nolen HW, Musallam HA, Pick RO..  (1989)  Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluation of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimida zolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases.,  32  (2): [PMID:2913310] [10.1021/jm00122a034]

3. Bedford CD, Harris RN, Howd RA, Goff DA, Koolpe GA, Petesch M, Koplovitz I, Sultan WE, Musallam HA..  (1989)  Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 3. Synthesis and evaluation of (alkenyloxy)-, (alkynyloxy)-, and (aralkyloxy)methyl quaternarized 2-[(hydroxyimino)methyl]-1-alkylimidazolium halides as reactivators and therapy for soman intoxication.,  32  (2): [PMID:2913311] [10.1021/jm00122a035]

Source

Source(1):

• Scientific Literature